
Ruta Jasaityte
@jasaityteruta
Cardiologist. 🇱🇹 in 🇧🇪 supporting 🇺🇦. Interest in echocardiography, heart failure, cardiooncology.
@HartcentrumH @JessaZiekenhuis
ID: 1325176448450224128
07-11-2020 20:41:14
1,1K Tweet
482 Takipçi
843 Takip Edilen




This meta-analysis shows consistent sex differences in VO₂, CO, and a-vO₂Diff in 3 invasive and 2 non-invasive studies Females with #HFpEF suffer a ‘double-hit’: impaired CO augmentation and reduced O₂ extraction. goo.gl/scholar/W2NhFu #ScholarAlerts Rachel Skow, PhD




This score will help distinguish severe from mild ICI-myocarditis. Many clinical implications‼️ In my opinion, this is one of the most clinically relevant papers on this topic to date. DrJE-Salem European Society of Cardiology Journals academic.oup.com/eurheartj/adva…


Very informative presentation by DrJE-Salem ⚠️ don't hurry up with antiarrhythmic therapy in ICI induced severe arrythmias and be aware of increased risk for developing of high grade conduction disorders #ESCardioOnc2025 #cardiooncology


Congratulations to Steve Foulkes for winning the YIA of #ESCardioOnco2025! #ExertTheBreathless breast cancer survivors to detect HFpEF❗️ But the question remains - is it a result of previous cancer treatment or a by-stander due to shared risk factors❓ #cardiooncology #CPET


🧵1/ Half of patients with exertional dyspnea due to HFpEF are missed by current diagnostic algorithms (H2FPEF, HFA-PEFF) ( Yogesh Reddy et al) Our multicenter study (n=2,452) in @JASEcho identifies a crucial missing link: 👉 the mPAP/CO slope





Prescribing aerobic #exercise to healthy people and #patients with heart disease or elevated risk: stepping away from using % of peak effort (%HRpeak, etc) but going for a threshold-based approach (ventilatory thresholds): far more precise and effective link.springer.com/article/10.100…


4 #echofirst views, 1 LAA thrombus American Society of Echocardiography Chittur Sivaram Edgar Argulian Marian VanDyck-Acquah MD FASNC FASE FACC Fadi Sawaya Antonio Frangieh, MD, MPH, FACC, FSCAI Jose Carlos Fernández Camacho Angel Caldera EchoTalk Echocardiography Patrycja Galazka Wally A. Omar, MD Oscar Mendiz Ana Paula Tagliari Maan Malahfji Ruta Jasaityte Vineeta Ojha Jadranka Stojanovska MD MS FSCMR Jason N. Johnson, MD MHS Dr. Ahmed Alomrani

Reduced echo monitoring every 6 months is safe and feasible for low risk HER2+ BC patients, per #Anthony Yu et al. A key step toward evidence-based, risk-adapted monitoring. #CardioOnc #CTRCD JACC Journals Kazuhiro Sase dineshpmcc International Cardio-Oncology Society
